Chinese scientists use supercomputer to cut new drug screening time from years to seconds
Chinese scientists have developed an AI platform called GalaxyVS, utilizing the Tianhe supercomputer, to drastically reduce drug screening times. This platform can analyze vast chemical compound libraries, accelerating the identification of potential drug candidates for various diseases. The system achieves a million-fold increase in speed compared to previous supercomputing methods for molecular docking, potentially revolutionizing treatment development for conditions like cancer and infectious diseases. AI
IMPACT Accelerates drug discovery pipelines, potentially leading to faster treatments for diseases like cancer and infectious diseases.